TrialInternational journal of hematology2006

Feasibility and efficacy of high-dose melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) chemotherapy with or without rituximab followed by autologous stem cell transplantation for aggressive and relapsed non-Hodgkin's lymphoma.

Li-na Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.